Literature DB >> 27122104

Cannabinoid hyperemesis syndrome and the onset of a manic episode.

Phillip Gregoire1, Michael Tau1, David Robertson1.   

Abstract

Cannabinoid hyperemesis syndrome is a rare, recently described, clinically diagnosed condition that is characterised by a chronic history of cannabis use, cyclic nausea and vomiting, symptomatic relief with hot water bathing, and resolution with cessation of use. We present a case of this syndrome concurrent in a patient with bipolar mania. We suggest that a 3-week period of vomiting in the context of this syndrome contributed to the precipitation of a manic episode by lowering mood stabiliser serum levels, and that this syndrome will have significant consequences for the patient's mental health. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27122104      PMCID: PMC4854155          DOI: 10.1136/bcr-2016-215129

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Drug abuse and bipolar disorder: comorbidity or misdiagnosis?

Authors:  E Sherwood Brown; T Suppes; B Adinoff; N Rajan Thomas
Journal:  J Affect Disord       Date:  2001-07       Impact factor: 4.839

2.  Cannabinoid hyperemesis: a case series of 98 patients.

Authors:  Douglas A Simonetto; Amy S Oxentenko; Margot L Herman; Jason H Szostek
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

3.  Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study.

Authors:  R W McCallum; I Soykan; K R Sridhar; D A Ricci; R C Lange; M W Plankey
Journal:  Aliment Pharmacol Ther       Date:  1999-01       Impact factor: 8.171

4.  Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder.

Authors:  A J Gelenberg; J M Kane; M B Keller; P Lavori; J F Rosenbaum; K Cole; J Lavelle
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

Review 5.  Cyclic vomiting syndrome: the corticotropin-releasing-factor hypothesis.

Authors:  Y Taché
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

6.  Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse.

Authors:  Siva P Sontineni; Sanjay Chaudhary; Vijaya Sontineni; Stephen J Lanspa
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

7.  Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse.

Authors:  J H Allen; G M de Moore; R Heddle; J C Twartz
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

8.  Cannabinoid hyperemesis syndrome: a case report and review of pathophysiology.

Authors:  Corina L Iacopetti; Clifford D Packer
Journal:  Clin Med Res       Date:  2014-03-25

9.  Cannabinoid hyperemesis syndrome: an important differential diagnosis of persistent unexplained vomiting.

Authors:  James K Ruffle; Sanjin Bajgoric; Kiran Samra; Subashini Chandrapalan; Qasim Aziz; Adam D Farmer
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-12       Impact factor: 2.566

  9 in total
  1 in total

1.  Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome.

Authors:  Thangam Venkatesan; David J Levinthal; B U K Li; Sally E Tarbell; Kathleen A Adams; Robert M Issenman; Irene Sarosiek; Safwan S Jaradeh; Ravi N Sharaf; Shahnaz Sultan; Christopher D Stave; Andrew A Monte; William L Hasler
Journal:  Neurogastroenterol Motil       Date:  2019-06       Impact factor: 3.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.